实例探究 > Pfizer Builds on the Genedata Biopharma E2E Workflow Platform

Pfizer Builds on the Genedata Biopharma E2E Workflow Platform

公司规模
1,000+
地区
  • America
  • Europe
国家
  • United States
产品
  • Genedata Biologics
  • Genedata Bioprocess
技术栈
  • Data Management System
  • Artificial Intelligence
  • Machine Learning
实施规模
  • Enterprise-wide Deployment
影响指标
  • Cost Savings
  • Innovation Output
  • Productivity Improvements
技术
  • 分析与建模 - 机器学习
  • 平台即服务 (PaaS) - 数据管理平台
适用行业
  • 医疗保健和医院
  • 药品
适用功能
  • 产品研发
  • 质量保证
用例
  • 质量预测分析
服务
  • 数据科学服务
  • 系统集成
关于客户
Pfizer is the world’s largest pharmaceutical company, a research-based organization with significant R&D investment. The company's key research areas include inflammation and immunology, internal medicine, oncology, rare disease, and vaccines. Biotherapeutic discovery and development within Pfizer is centralized in the Biomedicine Design and Biotherapeutic PharmSci departments. With R&D teams spread across the globe, Pfizer delivers biotherapeutic treatments that benefit patients worldwide. The company has been a Genedata customer since 2015.
挑战
Pfizer, a global biopharma giant, faced the challenge of aligning workflows and centralizing data for more than 200 scientists located at 6 sites around the world. The company's diverse and growing biopharma R&D operations required a central system to share data and align large-molecule R&D processes. With R&D teams spread across the globe, vast amounts of data were being collected in silos, making it difficult for teams to share information. This impeded collaboration and led to process inefficiencies. After an aborted attempt with a develop-as-you-go approach, Pfizer decided to evaluate the market in search of a commercial enterprise data management system for their large-molecule R&D groups. The desired system would need to act as a backbone platform and central repository for Pfizer’s biological R&D workflows and include tools able to capture specific instrumental data, workflows, analyses, and each group’s unique contribution to the overall biological drug discovery process at Pfizer.
解决方案
After conducting a thorough market evaluation to identify an off-the-shelf enterprise system for large-molecule discovery, Pfizer decided to implement Genedata Biologics as their central repository for their biologics discovery data, including screening, molecular biology, engineering, expression, purification, and analytics. The platform works out of the box and includes unique and comprehensive built-in business logic for all major discovery technologies, such as phage and yeast display, hybridoma, or B-cell-based approaches, Pfizer was able to get up and running quickly. In addition, the platform’s open architecture made it possible for Pfizer to integrate it into their existing R&D and IT environment and to develop highly integrated custom tools on top. Three years after the deployment of Genedata Biologics, Pfizer decided to expand beyond discovery and implemented Genedata Bioprocess to support their large-molecule pharmaceutical development.
运营影响
  • As a commercial off-the-shelf (COTS) product, Genedata Biologics went into operation for the first R&D user groups in just a few weeks, followed by adoption across the entire Pfizer Biomedicine Design discovery organization.
  • The system is now used by more than 250 people in 15 groups located at 6 Pfizer R&D sites around the globe and supports 200+ distinct discovery projects, including more than 900,000 clones, 28,000 lead molecules, 900 cell lines, and tens of thousands of protein batches and their respective analytics and QC results.
  • The system has helped to improve quality of results by eliminating errors resulting from passing spreadsheets and other ad hoc data exchange.
  • The system has helped to standardize workflows and requests and allows specialized groups to work and operate more efficiently in a division-of-labor organization.
数量效益
  • Pfizer reported an increase, by a factor of as much as 10, in antibodies converted to full IgG per project.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。